Ellex Medical Lasers Limited announced the resignation of Mr. Malcolm Plunkett as a Director of the Company. Throughout his four and a half year tenure as a Director, Mr. Plunkett has been a full time executive in the business responsible for research and development and has made a significant contribution to the business. He will continue in this executive role concentrating on bringing the 2RT project through to market release and managing the business's research portfolio.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.265 AUD | 0.00% | +1.92% | +10.42% |
03-15 | Nova Eye Medical Completes Retail Entitlement Offer | MT |
02-22 | Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.42% | 42.54M | |
+10.22% | 226B | |
+12.99% | 198B | |
+18.09% | 142B | |
+28.66% | 111B | |
+2.09% | 65.26B | |
+14.70% | 54.36B | |
+6.68% | 50.94B | |
+8.29% | 44.8B | |
+2.60% | 36.8B |
- Stock Market
- Equities
- EYE Stock
- News Nova Eye Medical Limited
- Ellex Medical Lasers Limited Announces the Resignation of Malcolm Plunkett as A Director